{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Daytona Beach",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80750",
      "recalling_firm": "Product Quest Manufacturing LLC",
      "address_1": "330 Carswell Ave",
      "address_2": "N/A",
      "postal_code": "32117-4416",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0065-2019",
      "product_description": "dr. brandt, BB cream with signature FLEXITONE, SPF 30, 1 oz./30 g tube, Distributed by: Cosmetic Dermatology, Inc., Miami, FL 33172, UPC 6 63963 00828 7.",
      "product_quantity": "9,480 tubes",
      "reason_for_recall": "Failed Stability Specifications: separation of product and failure for actives.",
      "recall_initiation_date": "20180803",
      "center_classification_date": "20181016",
      "termination_date": "20210330",
      "report_date": "20181024",
      "code_info": "Lot: 161223D, Exp. 4/16/2019"
    }
  ]
}